logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Purine Antimetabolite class drugs

    FiltersReset Filters
    4 results

    • azathioprine

      (Azathioprine)
      AvKARE
      Usage: Azathioprine tablets are indicated for preventing rejection in renal transplants and managing active rheumatoid arthritis to reduce symptoms. It may be used alongside certain medications, but combined use with DMARDs has not been studied. Patient survival outcomes in transplants vary based on several factors.

    • azathioprine

      (Azathioprine)
      Amneal Pharmaceuticals NY LLC
      Usage: Azathioprine tablets are indicated to prevent rejection in renal homotransplantation and to manage active rheumatoid arthritis, reducing its signs and symptoms. Caution is advised when combining with other disease-modifying anti-rheumatic drugs, as their combined effects have not been studied.

    • cladribine

      (Cladribine)
      Hisun Pharmaceuticals USA, Inc.
      Usage: Cladribine Injection, USP is indicated for treating active Hairy Cell Leukemia, characterized by clinically significant anemia, neutropenia, thrombocytopenia, or related disease symptoms.

    • mavenclad

      (Cladribine)
      EMD Serono, Inc.
      Usage: MAVENCLAD is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including relapsing-remitting and active secondary progressive diseases. It is recommended for patients who have not adequately responded to or cannot tolerate other MS treatments. It is not recommended for clinically isolated syndrome (CIS).